This positive recommendation confirms the good safety and tolerability profile of lanifibranor. About lanifibranor Lanifibranor, Inventiva’s lead product candidate, is an orally-available small ...
Jonathan Kelcher has given his Buy rating due to a combination of factors that suggest positive future performance ... justifying the Buy recommendation. In another report released on November ...
The DMC review supports the continuation of the NATiV3 clinical trial without modification to the current trial protocol. This positive recommendation confirms the good safety and tolerability profile ...
Roblox (NYSE:RBLX) just received some positive recommendation upgrades in the recent sprint. Morgan Stanley hiked the target to $65 from $38, stating that Roblox could double the revenue with more ...
The DMC review supports the continuation of the NATiV3 clinical trial without modification to the current trial protocol. This positive recommendation confirms the good safety and tolerability profile ...
Inventiva (IVA) has released an update. Inventiva has announced a positive recommendation from the Data Monitoring Committee for its NATiV3 Phase 3 clinical trial of lanifibranor, highlighting the ...
Roblox (NYSE:RBLX) just received some positive recommendation upgrades in the recent sprint. Morgan Stanley hiked the target to $65 from $38, stating that Roblox could double the revenue with more ...